Treatment of fibromyalgia with ubiquinone 10 and succinic acid
OwnerPaul A. Sneedinventor
Life of this patent
Estimating the term…
Abstract
A method is described for using a combination of ubiquinone 10 and succinic acid in the treatment of human patients afflicted with fibromyalgia to alleviate one or more symptoms associated with that disease state. Fibromyalgia positive patients treated buccally, sublingually or by oral ingestion administration of ubiquinone 10 and succinic acid enjoy a reduction in clinical symptoms of the disease.
Claims20
A method for treating a human patient suffering from fibromyalgia to produce a therapeutic response in said patient, said method comprising the step of administering to the patient ubiquinone 10 and succinic acid each at a dose of about 5 to about 500 mg/70 kg patient.
A pharmaceutical composition comprising therapeutically effective amounts of ubiquinone 10 and succinic acid as the active ingredients, and a pharmaceutically acceptable carrier therefor.
Dependencies are inferred from the claim text.